Hirsutism

DENVER — A prediction model that integrates machine learning-derived measures of ovarian volume, anti-Müllerian hormone levels and other clinically-derived diagnostic endpoints accurately predicted polycystic ovary syndrome.

After years of advocacy and research, clinicians increasingly recognize the physical symptoms of polycystic ovary syndrome. Yet, many women with PCOS have a range of serious psychosocial comorbidities that often go unaddressed.

Hormonal dysregulation seen in polycystic ovary syndrome can cause a cascade of issues for women, from hirsutism and weight gain to subfertility and type 2 diabetes. Yet beyond the reproductive years, the condition is often ignored.

Findings on the use of inositol for managing polycystic ovary syndrome are inconclusive, with results varying based on therapy, trial design and outcomes reported, according to a systematic review and meta-analysis.

Magnesium supplementation for 10 weeks led to no beneficial effects for women with polycystic ovary syndrome experiencing hyperandrogenism, hirsutism and impaired sleep quality, researchers reported in Health Science Reports.

Hormonal treatment combined with laser hair removal achieved better results in patients with polycystic ovarian syndrome with hirsutism compared with the combination of metformin and laser hair removal or hair removal alone.